Mentor
This article was originally published in The Gray Sheet
Executive Summary
Final module of a silicone gel-filled breast implant PMA application is filed with FDA. Advisory panel review is likely, the firm says (1"The Gray Sheet" Nov. 3, 2003, p. 22). Competitor Inamed received panel endorsement of its PMA Oct. 15 (2"The Gray Sheet" Oct. 20, 2003, p. 3)...
You may also be interested in...
Mentor Brachy Sales May Rise With ASC Code; Firm Seeds Women’s Health
Mentor contends that the addition of prostate brachytherapy to the list of ASC covered services, combined with resolution of the firm's supply problems, will boost Q3 sales for the segment
Inamed Silicone Implant Patient Monitoring Plans Allay Rupture Concerns
Inamed's proposal to closely follow patients implanted with silicone gel-filled breast prostheses helped sway FDA's General & Plastic Surgery Devices Panel to recommend conditional approval of the firm's PMA by a 9-6 margin
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.